PatientsVille.com Logo


Beer Medical Research Studies

Up-to-date List of Beer Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Beer Medical Research Studies

Rank Status Study
1 Unknown  Acute and Residual Effects of Caffeinated Beer
Conditions: Neurobehavioral Manifestations;   Drug Related Sleep Disturbance;   Alcohol Intoxication
Interventions: Drug: Caffeinated Alcoholic Beer;   Drug: Non-Caffeinated Alcoholic Beer;   Drug: Caffeinated Non-Alcoholic Beer;   Drug: Non-Caffeinated, Non-Alcoholic Beer
Outcome Measure: Simulated Driving Task, Psychomotor Vigilance Test, Profile of Mood States, Subjective Hangover Ratings
2 Unknown  Minimizing Risk and Maximizing Outcomes in Geriatric Patients Through Integrated Clinical Pharmacy Services in an Innovative Model of Community Practice
Conditions: Medication Adherence;   Health Literacy;   Geriatric Patient Care Improvement;   Pharmacy Economic Improvement
Interventions: Behavioral: Medication adherence consultation;   Other: Medication problems assessment;   Other: Beer's Criteria Assessment;   Behavioral: Health Literacy Assessment
Outcome Measures: Medication adherence;   Medication related problems;   Beers criteria medications;   Economic impact;   Health literacy;   Optimizing Anthropometrics;   Quality of Life
3 Unknown  Residual Effects of Intoxication on Student Performance
Conditions: Alcoholic Intoxication;   Neurobehavioral Manifestations
Intervention: Drug: Beer (alcohol)
Outcome Measures: cognitive function in response to heavy drinking;   self-reported residual effects of heavy drinking;   academic function in response to heavy drinking;   reaction time affected by residual effects of heavy drinking;   effectiveness of psychomotor vigilance testing as a fitness-for-duty test
4 Unknown  Donepezil Double Blind Trial for ECT Memory Disfunction
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Intervention: Drug: Donepezil
Outcome Measures: Data will be analyzed using SPSS for Windows.;   Results of the memory and neurocognitive measures will be examined;   using repeated MANOVA with before, within and after ECT treatment.
5 Unknown  Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
Condition: Pathological Gambling
Interventions: Device: Real Deep TMS;   Device: Sham Deep TMS
Outcome Measures: SOGS (South Oaks Gambling Screen);   Dannon Ainhold Gambling Scale;   visual analogue scale;   Hamilton Depression 24 items;   Hamilton Anxiety scale;   Yale-Brown Obsessive Compulsive Scale (Y-BOCS);   Clinical Global Impression Improvement (CGI-I);   Social Adaptational Scale(SAS)
6 Recruiting Randomized, Double-blind, Active-placebo Controlled Study of MDMA-assisted Psychotherapy in People With Chronic PTSD
Condition: Posttraumatic Stress Disorder (PTSD)
Interventions: Drug: Active placebo dose MDMA;   Drug: Full dose MDMA;   Drug: 125 mg MDMA (open label)
Outcome Measures: Clinician Administered PTSD Scale (CAPS);   Clinician-Administered PTSD Scale;   Beck Depression Inventory - II;   Global Assessment of Functioning (GAF);   Pittsburgh Sleep Quality Index;   Posttraumatic Diagnostic Scale (PDS);   Peak Systolic blood pressure;   Peak diastolic blood pressure;   Peak heart rate (HR);   Peak body temperature;   Peak subjective units of distress (SUD);   End-point systolic blood pressure;   End-point diastolic blood pressure;   End-point heart rate (HR);   End-point body temperature;   End-point Subjective Units of Distress (SUD);   Pre-drug systolic blood pressure;   Pre-drug diastolic blood pressure;   Columbia Suicide Severity Rating Scale (CSSRS);   Pre-drug heart rate;   Pre-drug body temperature;   Pre-drug Subjective Units of Distress (SUD)
7 Unknown  Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study
Conditions: OCD;   Schizophrenia
Intervention: Drug: Escitalopram
Outcome Measures: 1. Yale-Brown Obsessive Compulsive Scale (Y-BOCS) Symptom Checklist;   2. Positive and negative symptoms scale ( PANSS);   3. The Clinical Global Impression scales (CGI) consist of two sub-scales: The Severity of illness (CGI-S) and the Global improvement (CGI-I).;   4. Blood lipids and blood glucose prior to escitalopram up-titration over 20mg/d and at last visit;   5. EKG and physical examination will be performed at baseline 6. AE checklist at every visit 7. Recent and concomitant medications at every visit
8 Unknown  Transcranial Magnetic Stimulation (TMS) in Schizophrenia
Condition: Schizophrenia
Interventions: Device: DEEP TMS H1 coil;   Device: Deep H1 coil TMS
Outcome Measures: 1.Auditory hallucinations Rating Scale developed by Hoffman and colleagues (2003) 2.SAPS 3.CGI 4.SANS 5.GAF;   Q-LES-Q;   QIDS-SR16;   CTAHE
9 Recruiting Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Intervention: Biological: Ipilimumab
Outcome Measures: Fraction of patients who achieve an undetectable PSA (=< 0.2ng/ml);   Time to PSA progression;   Time to progression by any measure;   Time to death from any cause;   Number of patients with IRAEs;   Correlation between IRAEs and clinical outcomes;   Ratio of T regulatory cells to T effector cells;   Immune Response
10 Unknown  The Efficacy of Alpha-blockers for Expulsion of Distal Ureteral Stones
Condition: Renal Colic
Interventions: Drug: Alfuzosin;   Drug: Tamsulosin
Outcome Measures: frequency of stone expulsion;   time to stone expulsion;   analgesics consumption
11 Unknown  EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA
Condition: Primary Open Angle Glaucoma
Interventions: Device: external slt;   Device: standard slt
Outcome Measures: Intra Ocular Pressure values as a measure for treatment success;   Use of supplementary treatment for lowering intraocular pressure
12 Recruiting Prehospital Cerebral Oxygenation During Cardiopulmonary Resuscitation (CPR)
Condition: Cardiac Arrest
Outcome Measure: prognostic value
13 Recruiting Measuring Effects of Alcohol on Brain Chemistry
Conditions: Magnetic Resonance Spectroscopy;   Ethanol;   Spectroscopy
Intervention: Drug: Alcohol
Outcome Measures: What is the correlation between measured blood and breath alcohol level and ethanol level concentration computed from MRS.;   How does ethanol administration affect the brain metabolites, especially regarding glutamate?;   Does ethanol administration similarly affect the metabolite activities in all the regions of the brain Gray and White matter?
14 Recruiting Hyper Baric Oxygen Therapy (HBOT) for Spontaneous Osteonecrosis of the Knee
Condition: Spontaneous Osteonecrosis of the Knee
Intervention: Biological: Weight reduction
Outcome Measures: Efficacy;   Safety;   Reduction In AVN size by MRI
15 Recruiting Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.
Condition: Smoking Cessation
Interventions: Device: Sham Treatment;   Device: Active dTMS Treatment
Outcome Measures: Continuous Quit Rate;   Number of Cigarettes Smoked Per Day
16 Unknown  Evaluation of a Serology Diagnostic Kit for the Detection of Genital Mycoplasma in Pregnancy
Conditions: Genital Mycoplasma Infection;   High Risk Pregnancy;   Preterm Labor
Outcome Measures: Efficacy of the novel serology kit;   Antibody titer according to gestational age;   Correlation between culture and serology;   Correlation between antibody titer and pregnancy outcome
17 Unknown  Ibuprofen Suppositories Administration in Infants and Children
Condition: Fever
Intervention: Drug: ibuprofen suppositories
Outcome Measure: Fever decrease
18 Recruiting A Study of the Efficacy and Safety of RoActemra/Actemra in Patients With Rheumatoid Arthritis.
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra/Actemra!
Outcome Measures: Efficacy: Patient-reported outcome of disease activity;   Efficacy: Change in disease activity, scored on CDAI/SDAI;   Efficacy: Proportion of patients in remission/with lowered disease score;   Efficacy: Reduction/discontinuation of parallel therapies.;   Patient-reported quality of life assessment;   Safety: Incidence of adverse events;   Safety: Assessment of immunogenicity
19 Recruiting A Study of LY2875358 in Non Small Cell Lung Cancer (NSCLC) Participants
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: LY2875358;   Drug: Erlotinib
Outcome Measures: Proportion of Participants Exhibiting a Confirmed Complete Response (CR) or Partial Response (PR) (Overall Response Rate [ORR]);   Progression Free Survival (PFS);   Time to Progressive Disease (TTPD);   Change in Tumor Size (CTS);   Proportion of Participants Exhibiting a Stable Disease (SD) or a confirmed CR or PR (Disease Control Rate [DCR]);   Duration of Response (DoR);   Overall Survival (OS);   Change from Baseline in European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ) C30 (QLQ-C30) and Lung Cancer 13 (QLQ-LC13);   Change from Baseline in EuroQol 5-Dimensional Scale (EQ-5D);   Pharmacokinetics (PK): Area Under the Concentration Time Curve During a Dosing Interval (AUCtau) of LY2875358;   Proportion of Participants with Anti-LY2875358 Antibody Response
20 Unknown  Alcohol 20% for Separation of Pterygium and Comparison of Different Wound Closure Methods
Condition: Pterygium
Intervention: Procedure: pterygium surgery using alcohol 20% for tissue separation and bare sclera as wound closure technique
Outcome Measures: postoperative complications;   pterygium recurrence;   patient satisfaction;   corneal topography;   endothelial cell density;   evaluation of risk factors for pterygium recurrence (ex. exposure to UV-light, family history ...)

These studies may lead to new treatments and are adding insight into Beer etiology and treatment.

A major focus of Beer research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Beer